Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer
After NAT and resection, advanced resectability stage was not associated with worse OS indicating the value of this approach for borderline resectable and locally advanced IPMN-derived pancreatic cancer. The benefit of NAT in resectable disease is unclear and may require an individualized approach. Biological treatment effect can be assessed with CA19-9 and confirmed by pathologic response.
Authors
- Po Hong Tan
- Greg D. Sacks (ORCID: https://orcid.org/0000-0003-1205-6477)
- Giampaolo Perri (ORCID: https://orcid.org/0000-0002-2072-7114)
- Beat Peter Müller-Stich (ORCID: https://orcid.org/0000-0002-8552-8538)
- Thomas Hank (ORCID: https://orcid.org/0000-0001-8087-2295)
- Marc G. Besselink (ORCID: https://orcid.org/0000-0003-2650-9350)
- Alessio Marchetti (ORCID: https://orcid.org/0009-0006-3365-7713)
- Kelly J. Lafaro (ORCID: https://orcid.org/0000-0002-7070-7269)
- Adrian T. Billeter (ORCID: https://orcid.org/0000-0001-8724-4793)
- Katherine A. Morgan (ORCID: https://orcid.org/0000-0002-2874-8737)
- Jörg Kaiser (ORCID: https://orcid.org/0000-0003-3980-4340)
- Giovanni Marchegiani (ORCID: https://orcid.org/0000-0002-6824-4533)
- Benedict Kinny‐Köster (ORCID: https://orcid.org/0009-0003-7040-9725)
- Ingmar F. Rompen (ORCID: https://orcid.org/0000-0002-0257-1654)
- Zhi Ven Fong (ORCID: https://orcid.org/0000-0001-6398-413X)
- Christopher L. Wolfgang (ORCID: https://orcid.org/0009-0000-5817-6146)
- Joseph R. Habib (ORCID: https://orcid.org/0000-0003-3445-2278)
- Brady A. Campbell (ORCID: https://orcid.org/0000-0002-0792-6928)
- Lois A. Daamen (ORCID: https://orcid.org/0000-0001-9227-7178)
- Jing He (ORCID: https://orcid.org/0000-0002-1954-2892)
- D. Brock Hewitt (ORCID: https://orcid.org/0000-0001-6556-3830)
- Max Miller (ORCID: https://orcid.org/0000-0002-4936-2243)
- P. Andel (ORCID: https://orcid.org/0009-0006-9341-9282)
- Ammar A. Javed (ORCID: https://orcid.org/0000-0002-5463-5250)
- I. Quintus Molenaar
- O.R. Busch
- Markus W. Büchler
- Martin Loos
- Riccardo Pellegrini (ORCID: https://orcid.org/0009-0006-0597-9360)
Institutions
- Champalimaud Foundation (PT)
- University of Padua (IT)
- University of Basel (CH)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- WinnMed (US)
- University Medical Center Utrecht (NL)
- NYU Langone Health (US)
- St. Antonius Ziekenhuis (NL)
- Mayo Clinic in Florida (US)
- Johns Hopkins Hospital (US)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/sla.0000000000006687
- Citations
- 4
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 4.18